COPD profiles and treatable traits using minimal resources: identification, decision tree and stability over time

Abstract

Background and objective Profiles of people with chronic obstructive pulmonary disease (COPD) often do not describe treatable traits, lack validation and/or their stability over time is unknown. We aimed to identify COPD profiles and their treatable traits based on simple and meaningful measures; to develop and validate a decision tree and to explore profile stability over time. Methods An observational, prospective study was conducted. Clinical characteristics, lung function, symptoms, impact of the disease (COPD Assessment Test—CAT), health-related quality of life, physical activity, lower-limb muscle strength and functional status were collected cross-sectionally and a subsample was followed-up monthly over six months. A principal component analysis and a clustering procedure with k-medoids were applied to identify profiles. A decision tree was developed and validated cross-sectionally. Stability was explored over time with the ratio between the number of timepoints that a participant was classified in the same profile and the total number of timepoints (i.e., 6). Results 352 people with COPD (67.4 ± 9.9 years; 78.1% male; FEV1 = 56.2 ± 20.6% predicted) participated and 90 (67.6 ± 8.9 years; 85.6% male; FEV1 = 52.1 ± 19.9% predicted) were followed-up. Four profiles were identified with distinct treatable traits. The decision tree included CAT (< 18 or ≥ 18 points); age (< 65 or ≥ 65 years) and FEV1 (< 48 or ≥ 48% predicted) and had an agreement of 71.7% (Cohen’s Kappa = 0.62, p < 0.001) with the actual profiles. 48.9% of participants remained in the same profile whilst 51.1% moved between two (47.8%) or three (3.3%) profiles over time. Overall stability was 86.8 ± 15%. Conclusion Four profiles and treatable traits were identified with simple and meaningful measures possibly available in low-resource settings. A decision tree with three commonly used variables in the routine assessment of people with COPD is now available for quick allocation to the identified profiles in clinical practice. Profiles and treatable traits may change over time in people with COPD hence, regular assessments to deliver goal-targeted personalised treatments are needed.

Acute exacerbation prediction of COPD based on Auto-metric graph neural network with inspiratory and expiratory chest CT images

“…We looked up currently published studies related to AECOPD prediction [ [57] , [58] , [59] , [60] , [61] , [62] ] and employed these methods within the optimal group of our experiments to compare with our approaches. Additionally, we introduce the state-of-the-art GNN model NAGphormer [ 63 ], as well as the state-of-the-art 3D deep learning model for 3D medical images, 3DMSVIT [ 64 ].…”

Can Treatable Traits Be the Approach to Addressing the Complexity and Heterogeneity of COPD?

“…However, crucial aspects that may complicate the use of the treatable traits approach are that COPD patients may change their treatable traits over time, and this indicates that regular assessments to deliver goal-targeted personalised treatments are needed, 24 and sex-related differences were found, with most traits more prevalent and severe among women. 25 Furthermore, the concept of the presence of supertraits is emerging.…”

Lung Inflammation in alpha-1-antitrypsin deficient individuals with normal lung function

“…Alpha1-antitrypsin deficiency (AATD) is an inherited monogenic disorder associated with reduced circulating levels of AAT, linked to increased susceptibility to chronic obstructive lung disease (COPD) [ 1 , 2 ]. COPD, one of the top five leading causes of death in the world, is a destructive lung condition with a slow progression [ 3 – 6 ]. AATD Individuals with COPD have a Two-to-eightfold increased rate of decline in FEV 1 (∆FEV 1 ) as compared to non-genetic COPD individuals [ 7 – 11 ].…”